Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.
about
Cannabinoids, eating behaviour, and energy homeostasis.The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice.Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.Peripheral targets in obesity treatment: a comprehensive update.New perspectives on the development of antiobesity drugs.A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents.Pharmacokinetic/pharmaco-dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ(9)-tetrahydrocannabinol challenge tests.Components of the cannabinoid system in the dorsal periaqueductal gray are related to resting heart rateExploring structural requirements for peripherally acting 1,5-diaryl pyrazole-containing cannabinoid 1 receptor antagonists for the treatment of obesity.Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice.Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: a PET study.A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis.Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and Associated Diseases.Synthesis of S-2-((S)-3-(4-chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-(methyl-d3 )butanamide-d5 , octadeuterated JD5037.Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice.
P2860
Q30357350-5B693C5E-3CD4-4D84-B179-3D133CADDEFEQ33822403-B5A51597-8319-4204-93E2-1D1F268C45CEQ35871872-DE348068-6468-441E-8D40-61954AC32805Q38194649-53DE7EB5-8D40-44CB-934A-0D0CF0A9B0AEQ38397340-F301C842-5A8A-43BB-9B64-281C13AF32F8Q38544824-C2D2CC69-619C-45D0-ADF1-F4D014DFDF7FQ38937489-08107E66-F6D6-4034-A39A-43A900823F50Q39697253-0D65EF53-7EBF-4423-A1DB-F5C0E9848EE2Q40726993-1F2AE858-E556-403B-ABE8-867D0BA161F1Q42373365-32F13559-F7DC-4ABC-93FA-2DFF11EA6DE6Q44010230-6B9EB5CA-5FC2-49FB-8834-9A27C3DDF36AQ47407342-8055C814-FB7A-42A0-9C8C-B1E9F5DA59C6Q47797514-A4309F19-56BE-4C22-A06E-1CF4F23D085AQ48091336-201705EB-C20A-48C0-9884-9A80AB76CCF5Q55049564-212F3D12-9E3A-4251-A7B1-A4B616CE3343
P2860
Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Peripheral selectivity of the ...... t TM38837 in healthy subjects.
@en
type
label
Peripheral selectivity of the ...... t TM38837 in healthy subjects.
@en
prefLabel
Peripheral selectivity of the ...... t TM38837 in healthy subjects.
@en
P2093
P2860
P921
P356
P1476
Peripheral selectivity of the ...... st TM38837 in healthy subjects
@en
P2093
Christian E Elling
Joop M A van Gerven
Marianne Fridberg
Marieke L de Kam
Niels Ole Jensen
Paul B Little
P2860
P304
P356
10.1111/BCP.12141
P407
P577
2013-12-01T00:00:00Z